CO [China Cord Blood] SC 13G/A: *The remainder of this cover page shall be

[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed but]

By | 2016-03-27T10:10:15+00:00 February 10th, 2014|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Announces Results of 2013 Annual General Meeting HONG KONG, China, December 17, 2013 - China Cord Blood Corporation At the Annual General Meeting, shareholders · ratified the appointment of KPMG as the independent auditors of the Company for the financial year ending March 31, 2014 and authorized any duly formed committee of the directors to fix]

By | 2016-02-29T12:50:16+00:00 December 16th, 2013|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Announces Results of 2013

[China Cord Blood Corporation Announces Results of 2013 Annual General Meeting HONG KONG, China, December 17, 2013 - China Cord Blood Corporation At the Annual General Meeting, shareholders · ratified the appointment of KPMG as the independent auditors of the Company for the financial year ending March 31, 2014 and authorized any duly formed committee of the directors to fix]

By | 2016-02-29T12:51:11+00:00 December 16th, 2013|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: (Original Filing)

[Chinard Bloodrporation Announces Results of 2013 Annual General Meeting HONG KONG, China, December 17, 2013 - Chinard Bloodrporation At the Annual General Meeting, shareholders ratified the appointment of KPMG the independent auditors of thempany for the financial year ending March 31, 2014 and authorized any duly formedmmittee of the directors to fix the remuneration of]

By | 2016-02-04T15:26:46+00:00 December 16th, 2013|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: Chinard Bloodrporation Announces Results of 2013 Annual General

[Chinard Bloodrporation Announces Results of 2013 Annual General Meeting HONG KONG, China, December 17, 2013 - Chinard Bloodrporation At the Annual General Meeting, shareholders ratified the appointment of KPMG the independent auditors of thempany for the financial year ending March 31, 2014 and authorized any duly formedmmittee of the directors to fix the remuneration of]

By | 2016-02-04T15:27:16+00:00 December 16th, 2013|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K/A: (Original Filing)

[EXPLANATORY NOTE Results of Operations and Financialndition Following thisver page are the unauditedndensednsolidated financial results for the three months and six months ended September 30, 2013 of thempany. Chinard Bloodrporation and Subsidiaries Unauditedndensednsolidated Balance Sheets (Amounts expressed in thousands, except shareta)]

By | 2016-02-04T15:28:52+00:00 December 12th, 2013|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K/A: EXPLANATORY NOTE Results of Operations and Financialndition Following

[EXPLANATORY NOTE Results of Operations and Financialndition Following thisver page are the unauditedndensednsolidated financial results for the three months and six months ended September 30, 2013 of thempany. Chinard Bloodrporation and Subsidiaries Unauditedndensednsolidated Balance Sheets (Amounts expressed in thousands, except shareta)]

By | 2016-02-04T15:29:20+00:00 December 12th, 2013|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2014 2Q14 New Subscribers Reached 15,928 2Q14 Revenue Up 10.3% YOY to RMB141.6 Million 2Q14 Operating Income Up 19.7% YOY to RMB56.3 Million Conference Call to be Held November 15, 2013 at 8:00 a.m. ET HONG KONG, China, November 14, 2013 -- China Cord]

By | 2016-02-29T12:55:13+00:00 November 14th, 2013|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar